Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.
about
Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccinesTrial Watch: Peptide-based anticancer vaccines.Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models.Trial Watch: Peptide vaccines in cancer therapy.Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.
P2860
Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.
@en
type
label
Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.
@en
prefLabel
Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.
@en
P2093
P2860
P356
P1476
Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.
@en
P2093
Chuanlin Ding
Dong Xiang
Goetz Kloecker
Huang-Ge Zhang
Jinwen Sun
Xiaoling Hu
Yunfeng Ma
P2860
P304
P356
10.4049/JIMMUNOL.1203216
P407
P577
2013-04-29T00:00:00Z